ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Otolaryngology

Top Otolaryngology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FELIPE MARTINEZ M.D.

Otolaryngology

4,390

$231K

1687
1552 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $51

MICHAEL BIBLIOWICZ D.O.

Otolaryngology

3,582

$165K

795
656 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $51

MORRIS KRAVECAS M.D.

Otolaryngology

3,579

$165K

970
877 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $51

VIJAYKUMAR ZAVERI M.D.

Otolaryngology

3,483

$184K

1150
1074 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $51

ANTONIO YONG M.D.

Otolaryngology

3,448

$97.6K

827
769 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 21%

$28
Average prescription price

Avg: $51

TODD KUPFERMAN MD

Otolaryngology

3,227

$166K

660
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$52
Average prescription price

Avg: $51

JULIO TORRES M.D.

Otolaryngology

2,942

$169K

803
715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$57
Average prescription price

Avg: $51

FREDRIC PULLEN M.D.

Otolaryngology

2,858

$156K

745
705 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 21%

$55
Average prescription price

Avg: $51

AGUSTIN ARRIETA M.D.

Otolaryngology

2,447

$187K

603
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 21%

$76
Average prescription price

Avg: $51

JAMES ATKINS MD

Otolaryngology

2,392

$104K

598
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 7%

39%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $51

ELLIS WEBSTER MD

Otolaryngology

2,169

$66.9K

417
350 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 7%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 21%

$31
Average prescription price

Avg: $51

CARL DRUCKER M.D.

Otolaryngology

2,149

$124K

858
757 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $51

MICHELE RICHARDS MD

Otolaryngology

2,135

$107K

473
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$50
Average prescription price

Avg: $51

MOISES MITRANI M.D.

Otolaryngology

2,099

$111K

879
765 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $51

HORACIO GROISMAN M.D.

Otolaryngology

1,927

$85.1K

701
642 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 21%

$44
Average prescription price

Avg: $51

JOSE RUIZ M.D.

Otolaryngology

1,872

$115K

481
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 21%

$61
Average prescription price

Avg: $51

IGNACIO RODRIGUEZ MD

Otolaryngology

1,832

$67.3K

674
561 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $51

PAUL KLEIDERMACHER M.D.

Otolaryngology

1,812

$116K

503
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$64
Average prescription price

Avg: $51

CHARLES GREENE MD

Otolaryngology

1,759

$80.5K

427
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $51

HERBERT MOSELLE MD

Otolaryngology

1,698

$69K

659
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $51

TEW SAK MD

Otolaryngology

1,616

$62K

408
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $51

ABRAHAM JAGUAN M.D.

Otolaryngology

1,616

$108K

620
555 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 21%

$67
Average prescription price

Avg: $51

HECTOR HERNANDEZ MD

Otolaryngology

1,611

$42.1K

569
518 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 21%

$26
Average prescription price

Avg: $51

JESSE SALMERON MD

Otolaryngology

1,592

$67.4K

560
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $51

OMAR FADHLI M.D.

Otolaryngology

1,551

$51.4K

601
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 21%

$33
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank